XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Why Is Algorand (ALGO) Price Down Today? Key Factors
Algorand (ALGO) is trading at $0.099536 on October 29, 2026, down 3.88% over the past 24 hours, slipping below the psychologically significant $0.10 level as se...
South Korean Regulators Inspect Bithumb After Employee Data Exposure Signs
Bithumb disclosed signs pointing to a possible exposure of employee data, prompting regulators to move to direct on-site review, per CryptoSlate reporting .
Sports Made Up 98.2% of Polymarket US Turnover in 30 Days: DeFi Rate
Sports contracts accounted for 98. 2% of Polymarket US turnover over a 30-day window, according to DeFi Rate.
Coinbase Denies Breach After Amplitude Incident Exposes Customer Data
Coinbase has denied that its own systems were breached after a security incident at third-party analytics provider Amplitude exposed customer data linked to the...
Polymarket Updates 5-Minute Bitcoin Contract Pricing
Polymarket is pricing its five-minute Bitcoin contracts using a 60-second average rather than a single point-in-time snapshot, according to the platform’s publi...
Intel, Oracle and IBM Object to OKX–ICE Tokenized Stock Plans
Intel, Oracle, IBM and IonQ have formally objected to the OKX–ICE tokenized stock plans, according to an October 26 public notice published by OKXICE — the join...
